<SEC-DOCUMENT>0001485003-18-000041-index.html : 20180405
<SEC-HEADER>0001485003-18-000041.hdr.sgml : 20180405
<ACCEPTANCE-DATETIME>20180405165345
ACCESSION NUMBER:		0001485003-18-000041
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180404
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180405
DATE AS OF CHANGE:		20180405

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eleven Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				262025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36296
		FILM NUMBER:		18741196

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-444-8550

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		STREET 2:		SUITE 1800
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ebio-form8xk2017earnings.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: ebio-form8xk2017earnings.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ebio-4qye17earningsrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: ebio-4qye17earningsrelease.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ebio4qye17earningsrel_image1.gif
<TEXT>
Document 3 - file: ebio4qye17earningsrel_image1.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ebio4qye17earningsrel_image2.gif
<TEXT>
Document 4 - file: ebio4qye17earningsrel_image2.gif

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>elevenlogoa06.jpg
<TEXT>
Document 5 - file: elevenlogoa06.jpg

</DOCUMENT>
</SEC-DOCUMENT>